Multi-ingredient supplementation for combating sarcopenia and polymorbidity

We discuss the premise and potential of multi-ingredient supplements (MIS) in the treatment of complex skeletal muscle (SkM) pathologies, and provide an updated review of literature on nutraceuticals in sarcopenia and sarcopenic obesity (SO) management, with an emphasis on single- vs. multi-ingredient protein-based formulations. Several meta-analyses have confirmed the synergistic benefits of combining resistance training (RT) with dietary protein supplementation in older adults with sarcopenia or physical frailty, with a potential ceiling effect at 1.5-1.7 g PRO/kg BW/day.Single-ingredient supplements with proven synergism with RT and clinical relevance for sarcopenia treatment include the major milk proteins (whey and/or casein) and creatine monohydrate. Vitamin D3, calcium, and/or n-3 polyunsaturated fatty acids are also recommended for mitigating concurrent micronutrient deficiencies, bone loss, and inflammation. More evidence is needed to justify monotherapy with leucine or leucine metabolites over high-quality protein sources.RCTs have demonstrated superiority of whey-based MIS compared to isocaloric and isonitrogenous placebo for enhancing SkM growth in both younger and older persons, including obese and nonobese sarcopenic subgroups, as confirmed by in vivo body composition and/or biopsy sampling.Multi-ingredient formulations containing high-quality milk proteins, creatine monohydrate, vitamin D3, calcium, and n-3 polyunsaturated fatty acids may therefore be recommended in the multimodal treatment of sarcopenia and sarcopenic obesity. Resistance training is the first-line treatment for musculoskeletal conditions and improves lean body mass, strength, and function in sarcopenia patients. Increased protein intake augments RT-induced muscle anabolism across clinical subpopulations, with recent evidence suggesting superiority of multi vs. single-ingredient protein-based supplements.